TScan Therapeutics Insider Trades

NASDAQ: TCRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.238+0.0098 (+4.29%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases: 3 · $145.53K
Sales: 0 · $0
Shares bought / sold: 161.80K / 0
Net activity: Net buying $145,526

TScan Therapeutics insider activity

Over the last 12 months, TScan Therapeutics insiders reported 5 transactions on SEC Form 4: 3 open-market purchases and 0 sales. Insiders bought $145,526 and sold $0 worth of stock, for net insider buying of $145,526. The most recent filing shows MacBeath Gavin (Chief Executive Officer) reporting a transaction in 1,000,000 shares on Oct 1, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TCRX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TCRX insider transactions

TScan Therapeutics insider transactions
Date	Insider	Type	Shares	Price	Value	Owned after	Filing
Oct 1, 2026	ZDRAVESKI ZORANSee Remarks	Award	300,000	—	—	304.72K	Form 4
Oct 1, 2026	MacBeath GavinChief Executive Officer	Award	1,000,000	—	—	1.05M	Form 4
Dec 23, 2025	Lynx1 Capital Management LP & Nichols Weston10% Owner	Buy	6,232	$0.8989	$5.60K	8.02M	Form 4
Dec 22, 2025	Lynx1 Capital Management LP & Nichols Weston10% Owner	Buy	75,500	$0.90	$67.95K	8.01M	Form 4
Dec 19, 2025	Lynx1 Capital Management LP & Nichols Weston10% Owner	Buy	80,069	$0.8989	$71.97K	7.94M	Form 4
May 20, 2025	Lynx1 Capital Management LP & Nichols Weston10% Owner	Buy	1,200,000	$1.20	$1.44M	7.95M	Form 4
May 19, 2025	Lynx1 Capital Management LP & Nichols Weston10% Owner	Buy	1,388,794	$1.20	$1.67M	6.75M	Form 4
Dec 13, 2024	Lynx1 Capital Management LP & Nichols Weston10% Owner	Buy	100,000	$2.90	$290.14K	5.36M	Form 4
Dec 12, 2024	Lynx1 Capital Management LP & Nichols Weston10% Owner	Buy	31,800	$3.01	$95.63K	5.26M	Form 4
Nov 15, 2024	Lynx1 Capital Management LP & Nichols Weston10% Owner	Buy	947	$4.34	$4.11K	5.23M	Form 4
Sep 23, 2024	Klencke BarbaraDirector	Buy	5,000	$5.29	$26.45K	45.00K	Form 4
Aug 26, 2024	Klencke BarbaraDirector	Buy	5,000	$5.53	$27.65K	40.00K	Form 4
Aug 23, 2024	ZDRAVESKI ZORANSee Remarks	Sale	164,686	$5.78	$952.12K	4.72K	Form 4
Aug 23, 2024	ZDRAVESKI ZORANSee Remarks	Option exercise	64,166	$2.49	$159.77K	169.40K	Form 4
Aug 23, 2024	ZDRAVESKI ZORANSee Remarks	Option exercise	13,125	$1.81	$23.76K	105.24K	Form 4
Aug 23, 2024	ZDRAVESKI ZORANSee Remarks	Option exercise	25,000	$3.27	$81.75K	92.11K	Form 4
Aug 23, 2024	ZDRAVESKI ZORANSee Remarks	Option exercise	54,895	$4.85	$266.24K	67.11K	Form 4
Aug 23, 2024	Klencke BarbaraDirector	Buy	5,000	$5.69	$28.45K	35.00K	Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4